Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2024 financial results and 2025 ...

With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

Gilead Sciences continues to focus on advancing medicines to combat diseases like HIV, viral hepatitis, COVID-19, and cancer, operating in over 35 countries with its headquarters in Foster City ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Jan 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab and ... for comment and more information about the settlement. Foster City, California-based Gilead collaborated with the CDC in the ...

"Gilead Sciences, Inc. (NASDAQ:GILD), headquartered in Foster City, CA, is one of the world’s largest and best-managed research-based biopharmaceutical companies that discovers, develops ...

Gilead Sciences, US Government Settle Patent Case ... a request for comment and more information about the settlement. Foster City, California-based Gilead collaborated with the CDC in the mid ...

(Reuters) - Gilead Sciences and the U.S. government have ... for comment and more information about the settlement. Foster City, California-based Gilead collaborated with the CDC in the mid ...

(Reuters) - Gilead Sciences (NASDAQ:GILD ... to a request for comment and more information about the settlement. Foster City, California-based Gilead collaborated with the CDC in the mid-2000s ...